These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Determination of amlodipine using terbium-sensitized luminescence in the presence of europium(III) as a co-luminescence reagent.
    Author: Al-Kindy SM, Al-Snedi A, Suliman FE, Al-Lawati HA.
    Journal: Luminescence; 2014 Sep; 29(6):657-62. PubMed ID: 24265217.
    Abstract:
    A sensitive time-resolved luminescence method for the determination of amlodipine (AM) in methanol and in aqueous solution is described. The method is based on the luminescence sensitization of terbium (Tb(3+) ) by formation of a ternary complex with AM in the presence of tri-n-octylphosphine oxide (TOPO) as co-ligand, dodecylbenzenesulfate as surfactant and europium ion as a co-luminescence reagent. The signal for Tb-AM-TOPO is monitored at λex  = 242 nm and λem  = 550 nm. Optimum conditions for the formation of the complex in aqueous system were 0.015 m Tris (hydroxylmethyl) amino methane buffer, pH 9.0, TOPO (1.0 × 10(-4) m), Eu(3+) (2.0 × 10(-7) m), dodecylbenzenesulfate (0.14%) and 6.0 × 10(-5) m of Tb(3+) , which allows the determination of 10-50 ppb of AM with a limit of detection of 1.2 ppb. The relative standard deviations of the method range between 0.1 and 0.2% indicated excellent reproducibility of the method. The proposed method was successfully applied for the assay of AM in pharmaceutical formulations and in plasma samples. Average recoveries of 98.5 ± 0.2% and 95.2 ± 0.2% were obtained for AM in tablet and plasma samples respectively.
    [Abstract] [Full Text] [Related] [New Search]